Show simple item record

FieldValueLanguage
dc.contributor.authorVosu, Joelen
dc.contributor.authorBritton, Philipen
dc.contributor.authorHoward-Jones, Annaleiseen
dc.contributor.authorIsaacs, Daviden
dc.contributor.authorKesson, Alisonen
dc.contributor.authorKhatami, Amenehen
dc.contributor.authorMarais, Benen
dc.contributor.authorNayda, Claireen
dc.contributor.authorOuthred, Alexanderen
dc.date.accessioned2020-09-14
dc.date.available2020-09-14
dc.date.issued2020en
dc.identifier.urihttps://hdl.handle.net/2123/23307
dc.language.isoenen
dc.rightsOther
dc.subjectCOVID-19en
dc.subjectCoronavirusen
dc.titleIs the risk of ibuprofen or other non‐steroidal anti‐inflammatory drugs increased in COVID‐19?en
dc.typeArticle, Letteren
dc.identifier.doi10.1111/jpc.15159
usyd.facultyFaculty of Medicine and Health, Sydney Medical Schoolen


Show simple item record

Associated file/s

There are no files associated with this item.

Associated collections

Show simple item record

There are no previous versions of the item available.